Department of Obstetrics/Gynecology and Reproductive Medicine, Stony Brook Medicine, Stony Brook, New York, USA.
Department of Psychology, The New School for Social Research, New York, New York, USA.
Prenat Diagn. 2020 Sep;40(10):1220-1227. doi: 10.1002/pd.5730. Epub 2020 May 19.
To analyze psychometric properties of two novel instruments assessing decisional distress and uncertainty experienced by individuals considering preimplantation genetic testing (PGT).
The new PGT Decisional Distress instrument (22 items) assesses negative/positive emotions. The new PGT Decisional Uncertainty instrument assesses Clarity about test benefits/disadvantages (5 items) and Certainty of having adequate information/support to make a good decision (7 items). Scales ranged from 0 to 4. Psychometrics (central tendencies, internal consistency reliability, and discriminant validity) were evaluated. Stratified analysis by decision stage was conducted. All participants had considered or used PGT in the previous 6 months.
N = 106 females (mean age 36.5 ± 4.8 years; 16% non-Caucasian; 9% Hispanic) across 16 US states completed an online anonymous questionnaire. On average, respondents reported minimal distress (mean 0.96), high clarity (mean 3.26), and high certainty (mean 3.06), particularly those who had already decided compared to undecided women (P ≤ .02). Instruments had excellent internal consistency (Cronbach's α's 0.92-0.94) and displayed sufficient inter-individual variability (SD's 0.75-0.89). Correlations confirmed expected patterns of association between instruments (P's < .01), indicating discriminant validity.
We document initial reliability and validity of new instruments to measure emotional distress and uncertainty in female patients who have recently considered PGT for single-gene or chromosomal disorders.
分析评估考虑进行胚胎植入前遗传学检测(PGT)的个体所经历的决策困扰和不确定性的两种新工具的心理计量学特性。
新的 PGT 决策困扰量表(22 项)评估负面/正面情绪。新的 PGT 决策不确定性量表评估对测试利弊的了解程度(5 项)和是否有足够的信息/支持做出良好决策的确定性(7 项)。量表范围为 0 至 4。评估心理计量学特性(集中趋势、内部一致性信度和判别有效性)。按决策阶段进行分层分析。所有参与者在过去 6 个月内都考虑过或使用过 PGT。
16 个美国州的 106 名女性(平均年龄 36.5 ± 4.8 岁;16%非白种人;9%西班牙裔)完成了在线匿名问卷。平均而言,受访者报告的困扰程度较低(平均 0.96),清晰度较高(平均 3.26),确定性较高(平均 3.06),尤其是那些已经做出决定的女性,与未做出决定的女性相比(P ≤.02)。这些工具具有极好的内部一致性(克朗巴赫的α值为 0.92-0.94),并表现出足够的个体间可变性(SD 值为 0.75-0.89)。相关性证实了工具之间预期的关联模式(P 值<.01),表明了判别有效性。
我们记录了用于衡量最近考虑单基因或染色体疾病的 PGT 的女性患者的情绪困扰和不确定性的两种新工具的初步可靠性和有效性。